CalciMedica, Inc. cash flow to debt ratio of -218.33% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

CalciMedica, Inc.'s free cash flow has decreased 0.25% from $-21.15M last year to $-21.21M, signaling decreasing performance

CalciMedica, Inc.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.

CalciMedica, Inc. has insufficient data to evaluate this check.

CalciMedica, Inc. has a net cash position, so leverage is healthy.

CalciMedica, Inc.'s interest coverage ratio is -17.18, which means that the company struggles to meet interest obligations, signaling financial risk.

CalciMedica, Inc. has insufficient data to evaluate this check.

CalciMedica, Inc.'s short-term assets of $13.53M exceed its short-term liabilities of $3.78M

CalciMedica, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

CalciMedica, Inc.'s return on equity of 4.09K%, is higher than 15.00%, indicating good performance

CalciMedica, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

CalciMedica, Inc. has insufficient public price history to evaluate earnings stability.

CalciMedica, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

CalciMedica, Inc. has negative free cash flow, indicating cash burn

CalciMedica, Inc.'s yearly earnings has decreased 115.78% since last year from $-13.70M to $-29.56M, signaling decreasing performance

CalciMedica, Inc.'s yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance

ROIC -674.61% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

CalciMedica, Inc. has insufficient revenue history to calculate 3-year revenue CAGR.

CalciMedica, Inc. has insufficient public price history to evaluate revenue consistency.

CalciMedica, Inc. has insufficient public price history to evaluate ROE consistency.

CalciMedica, Inc. has insufficient data to evaluate this check.

CalciMedica, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

CalciMedica, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

CalciMedica, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

CalciMedica, Inc. has insufficient data to evaluate this check.

CalciMedica, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

CalciMedica, Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails

CalciMedica, Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue